, . 1950- , , . , . . ( ) () D2- . , D2- (, ). D2- , , .[1] , . , . , (, ), , . 40 , .
, (), , . , . , . , (, ). . , , , . . , . . 4 20 , , , .
|
|
D2- . . D2-, (. 2.1), (5-HT2), , (<6 /). 5-HT2-, , D2- . D2- 5-HT2-, (. . 2.1), .[2]
2.1.
D1 | D2 | D3 | D4 | 5-HT2 | 5-HT2 | α1 | H1 | ACh | |
>10 000 | |||||||||
>1000 | |||||||||
0,5 | >1000 | ||||||||
0,4 | >1000 |
( ) . , (. . ). : Tamminga .A. Principles of the pharmacotherapy of schizophrenia.. In: Charney D.S., Nestler E.J., Bunney B.S., eds. Neurobiology of mental illness. New York: Oxford University Press, 1999: 274.
.
. : , . (, ) ( ). (, , ). (, , , ) .
|
|
. . . .[3]
. (), , ( ). , , . [4], .
D2- 5-HT2 . 5-HT2 , . . , . , .
.